PPD 3Q Revenues: $1.2 billion (+21%) 3Q Earnings: $9.1 million (-45%) YTD Revenues: $3.3 billion (+11%) YTD Earnings: $58.1 million (+69%) Comments: Clinical Development Services revenue was $1.0 billion in the quarter, up 19% and Laboratory Services revenue was $225.2 million, up 27%. Net authorizations of $1.2 billion, representing 33% growth over third quarter 2019 and resulting in a net book-to-bill ratio of 1.35x on a historical basis. Ending backlog of $7.9 billion, rep...